Nutrient quality
Utilization of the branded MenaQ7 subtype ensures superior systemic bioavailability and tissue utility. A 160 mcg dose aligns with clinical targets for supporting arterial flexibility and bone density maintenance.
| $ 38.00 | ||
| $ 38.00 | ||
Vitacost | $ 38.00 |
This tablet provides 160 mcg of Vitamin K2 using the branded MenaQ7 form. It is a focused supplement designed to help the body manage calcium without adding extra Vitamin D.
The tablet format is small and easy to take, though you should always take it with food. It is a reliable choice for those wanting a specific K2 dose from a high-quality source.
Utilization of the branded MenaQ7 subtype ensures superior systemic bioavailability and tissue utility. A 160 mcg dose aligns with clinical targets for supporting arterial flexibility and bone density maintenance.
The supplement facts are clearly detailed, identifying the exact microgram quantity and form of Vitamin K2. Usage instructions are straightforward, and the use of the MenaQ7 trademark adds technical clarity for the consumer.
High average ratings and a respectable review history indicate consistent product performance and reliability. Feedback suggests users find the single-ingredient K2 supplement valuable for their intended goals.
The price per serving is high compared to many similar Vitamin K2 supplements. While the quality is high, the market offers several more cost-effective options with the same microgram dosage of MK-7.
This Vitamin K2 supplement features the branded MenaQ7 form of MK-7 to support foundational cardiovascular health and structural bone density. MK-7 is the most bioavailable form of K2, offering long-term tissue retention and high biological activity.
A 160 mcg dose provides significant contribution toward daily health requirements for calcium regulation. By focusing exclusively on a single high-impact nutrient, the formulation provides deep support for systemic integrity and vascular wellness.
Vitamin K2 as MK-7 is provided in the branded MenaQ7 form, which is highly effective for supporting arterial health and preventing vascular calcification. The 160mcg dose is well-supported by clinical research for maintaining vascular elasticity and cardiovascular longevity.
By focusing on the MK-7 subtype, the formula ensures long-lasting activity in the bloodstream, allowing for more consistent protection compared to shorter-acting forms. This single-ingredient product is highly targeted for those prioritizing vascular structural health.
Branded MenaQ7 Vitamin K2 provides a focused dose of the MK-7 subtype for cardiovascular and bone health. This form of Vitamin K2 may support arterial flexibility and systemic longevity by directing calcium to aging tissues.
The therapeutic 160 mcg dose aligns with clinical research for long-term health maintenance. High bioactivity is ensured through the all-trans isomer found in the branded MK-7 source.
Vitamin K2 as MK-7 supports cardiovascular health by regulating calcium and promoting arterial elasticity. This product provides a clinical dose of a high-quality branded form for vascular integrity.
A 160 mcg dose of MenaQ7 MK-7 is meaningfully dosed for systemic cardiovascular support. Bioavailability is hampered by the tablet format, which requires a fat-containing meal for effective absorption.
Branded MenaQ7 MK-7 is the sole active ingredient, providing highly focused support for the activation of bone-building proteins like osteocalcin. This specific isomer of Vitamin K2 is critical for ensuring that minerals are directed away from soft tissues and into the skeletal matrix.
While this ingredient is a high-quality regulator of bone health, the absence of Vitamin D3 and structural minerals limits the formula's total efficacy. It serves as a potent signaling tool but lacks the synergy and raw materials for complete bone support.
| Ingredient | Amount per serving |
|---|---|
Vitamin K2 (Mena Q7) | 160 mcg |